Background: Neonatal lupus erythematosus (NLE) is an uncommon disease described mainly through isolated case reports and a few published series.

Objective: To examine the clinical and serological spectrum, and course of the disease in neonates with NLE and cutaneous involvement.

Methods: A retrospective study was performed that included all children with NLE that came to the Dermatology Department between 1995 and 2006.

Results: Eight children with a diagnosis of NLE with cutaneous involvement were identified, with a male:female ratio of 3:1. Anti-Ro antibodies were found in all cases and no cases with anti-RNP antibodies were found. Facial lesions were observed in all cases and in 7 cases the skin eruptions cleared within 4.3 months; the remaining patient was still in follow up when the data were collected. The clinical course of patients who were followed up was satisfactory.

Conclusions: In our series, NLE was three times more frequent in males. Involvement of sun-exposed areas, such as the face with annular lesions was the most common finding. We found one case of NLE with cutaneous involvement and persistent ductus arteriosus. Anti-Ro antibodies were found in all cases and skin eruptions cleared by 7 months of age, concurrent with the waning of the maternally derived antibodies. Four of the mothers were asymptomatic and unaware of their condition, emphasizing the importance of following up these patients due to the possibility of developing an autoimmune disease.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.anpedi.2008.10.019DOI Listing

Publication Analysis

Top Keywords

nle cutaneous
12
neonatal lupus
8
cutaneous involvement
8
anti-ro antibodies
8
antibodies cases
8
cases cases
8
cases skin
8
skin eruptions
8
eruptions cleared
8
cleared months
8

Similar Publications

Objective: To study the clinical features and laboratory parameters of neonatal lupus erythematosus (NLE) from India.

Patients And Methods: We analyzed case records of children diagnosed with NLE in the Pediatric Rheumatology Clinic at tertiary care centre from North India during the period January 1999 - December 2023.

Results: Twenty-four babies are diagnosed with NLE during the study period.

View Article and Find Full Text PDF
Article Synopsis
  • * A case report details a baby with NLE and MAS showing symptoms such as fever, convulsions, and rash, highlighting the seriousness of the condition.
  • * High-dose gamma globulin and steroids are recommended as initial treatments, and monitoring the rash is suggested to assess treatment effectiveness.
View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on neonatal systemic lupus erythematosus (NLE), an autoimmune disease in newborns, specifically examining cases where patients also had rare effusions like pleural or pericardial effusion.
  • Researchers collected and analyzed clinical data from 2011 to 2023, categorizing patients into two groups: those with effusions and those without, to compare their clinical characteristics.
  • Findings revealed that 24.44% of NLE patients experienced effusions, with significant differences in various lab results between groups, indicating a more severe clinical presentation in those with effusions, but all effusions eventually resolved on their own.
View Article and Find Full Text PDF

Genetics of Neonatal Lupus Erythematosus Risk and Specific Manifestations.

J Rheumatol

January 2025

L.T. Hiraki, MD, ScD, Genetics & Genome Biology, Research Institute, and Division of Rheumatology, The Hospital for Sick Children, and Division of Rheumatology, The Hospital for Sick Children, Toronto, Ontario, Canada.

Objective: Neonatal lupus erythematosus (NLE) is a passively acquired autoimmune disease in infants born to anti-Ro and/or anti-La autoantibody-positive mothers. Genetics may affect NLE risk. We analyzed the genetics of infants and anti-Ro antibody-positive mothers, with NLE and NLE-specific manifestations.

View Article and Find Full Text PDF

Exploring the role of GHRH antagonist MIA-602 in overcoming Doxorubicin-resistance in acute myeloid leukemia.

Oncotarget

April 2024

Dr. Philip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.

Acute myeloid leukemia (AML) is characterized by the rapid proliferation of mutagenic hematopoietic progenitors in the bone marrow. Conventional therapies include chemotherapy and bone marrow stem cell transplantation; however, they are often associated with poor prognosis. Notably, growth hormone-releasing hormone (GHRH) receptor antagonist MIA-602 has been shown to impede the growth of various human cancer cell lines, including AML.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!